A team of five Johns Hopkins University students won first place and $5,000 at the fifth annual Pfizer Case Competition at the Johns Hopkins Carey Business School earlier this month.
Fifteen Johns Hopkins scientists are among 3,000 individuals included on the annual Highly Cited Researchers list compiled by Clarivate Analytics, which was previously part of Thomson Reuters.
High-income countries are grappling with the challenge of caring for aging populations, many of whose members have chronic illnesses and declining capacity to manage activities of daily living. The 2017 Commonwealth Fund International Health Policy Survey of Older Adults in eleven countries showed that US seniors were sicker than their counterparts in other countries and, despite universal coverage under Medicare, faced more financial barriers to health care.
When: Tuesday, December 5, 2017 6:30 p.m. – 8:30 p.m. EST
Where: All Set Restaurant & Bar 8630 Fenton St. Silver Spring, MD 20910
It’s that time of the year again! Please join Capital Region chapter of Women In Bio as we celebrate the conclusion of an amazing 2017 at All Set Restaurant & Bar in Silver Spring, MD. Come mix & mingle with friends old and new over drinks and hors d’oeuvres, learn about the opportunities and resources that you have access to as WIB members, and participate in our raffle to win exciting prices!
Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Maryland Tech Council announced today that Nora D. Volkow, M.D., Director of the National Institute on Drug Abuse, National Institutes of Health (NIH) will kick off its new Innovation Speaker Series. Dr. Volkow will discuss the current state of the opioid crisis nationally and locally. Additionally, her presentation will cover what research has shown about this particular addiction, its prevention and treatment, and how science may help end the massive public health crisis. Key industry leaders are expected to attend this inaugural series event, which will take place Wednesday, November 29, 2017 at the Universities at Shady Grove from 7:30-9:30 a.m.
The Johns Hopkins University and Deerfield Management announced today the creation of Bluefield Innovations, a collaboration designed to catalyze the development of early stage therapeutics. Funded by Deerfield, an investment management firm committed to advancing health care, Bluefield Innovations will provide up to $65 million in initial funding over five years to support the commercialization of early stage therapeutic research at Johns Hopkins, with additional funding available to advance research that shows strong commercial potential.
Bioterrorism threats and infectious disease outbreaks are on the rise. Emergent BioSolutions Inc. (EBS) has a stream of revenues from FDA-approved drugs, as well as a full pipeline of drugs under development, to combat these health threats.
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched enhancements in its QIAGEN Clinical Insight (QCI) bioinformatics software automating the AMP/ASCO/CAP Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer, advancing precision medicine with the first solution to offer molecular pathologists critical information needed to guide oncologists’ treatment decisions.
FDA approval based on Phase III program demonstrating up to 51% reduction in asthma exacerbations, significant improvement in lung function and a 75% reduction in daily oral steroid use